IL6 and neoplasm: Another study also validated these results as DHMEQ inhibited 3D invasion of breast carcinoma cells through inhibition of matrix metalloproteinase (MMP), a peptidase important for extracellular matrix degradation in the tumor microenvironment, along with inhibition of IL-6 [31].